Indivior Pharmaceuticals, Inc. · NASDAQ:INDV

Anderson Woodrow D bought 1,500 Indivior Pharmaceuticals, Inc. shares (Form 4)

Traded Aug 27, 2026 · Filed Aug 27, 2026

On Aug 27, 2026, Anderson Woodrow D (Chief Accounting Officer) bought 1,500 Indivior Pharmaceuticals, Inc. shares at US$35.69 for US$53,535, leaving 27,638 shares. Filed Aug 27, 2026 (Form 4).

Bought
1,500 shares
Price
US$35.69
Value
US$53,535
Holding after
27,638 shares
Trading plan
No
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 27, 2026Common StockBuy1,500US$35.6927,638Direct

Source

View original at SEC

Related